102例血管免疫母细胞性T细胞淋巴瘤的临床病理学特征分析-东南大学学报医学版

102例血管免疫母细胞性T细胞淋巴瘤的临床病理学特征分析

单位：1. 江苏省人民医院浦口分院/南京市浦口区中心医院病理科, 江苏南京 211800;
2. 江苏省肿瘤医院病理科, 江苏南京 210009

分类号：R733

出版年·卷·期（页码）：2023·42·第三期（446-451）

摘要：

目的: 探究血管免疫母细胞性T细胞淋巴瘤(AITL)的临床病理学特点。方法: 分析102例AITL的临床特点以及病理组织学、免疫表型及分子遗传学特征。结果: 淋巴结结构被肿瘤细胞全部或部分破坏。高内皮小静脉(HEVs)形成分枝状结构网,其内可见肿瘤细胞、免疫母细胞、组织细胞、浆细胞、嗜酸粒细胞弥漫浸润或浸润于副皮质区。肿瘤细胞胞浆透亮,被滤泡树突细胞(FDC)网围绕。免疫组织化学染色结果显示,肿瘤细胞表达CD3(102/102)、CD4(93/102)、CD5(87/102),并且表达多个滤泡辅助T细胞相关标志物,如BCL6(79/102)、CD10(44/102)、PD1(75/102)、CXCL13(43/102)和诱导型共刺激因子(ICOS)(99/102)。FDC标志物CD21和CD23染色,清晰地显示滤泡外增生的FDC网。NGS检测了40例AITL病例,发现4个特征性基因突变,即TET2(31/40)、DNMT3A(9/40)、IDH2(18/40)和RHOA(23/40)。结论: AITL的临床病理表现复杂,其诊断需要结合临床、组织病理学、免疫组织化学、分子遗传学作综合判断;相较于其他滤泡辅助T细胞标志物,ICOS更有助于AITL的诊断。

Objective: To clarify the clinicopathologic features on angioimmunoblastic T-cell lymphoma(AITL). Methods: The clinical, histomorphological, immunohistochemical, molecular and genetic features of 102 patients with AITL were analyzed. Results: Lymph nodes involved by AITL typically showed partial or complete architectural effacement with perinodal extension.The infiltrate was usually diffuse or paracortical, composed of a polymorphous population of small to medium sized lymphocytes, scattered immunoblasts, histiocytes,plasma cells, and eosinophils amid prominent networks of arborizing high endothelial venules(HEVs).The neoplastic T cells were usually enwrapped by follicular dendritic cell(FDC)meshworks with clear cytoplasm. Immunophenotypically, the neoplastic cells expressed CD3(102/102), CD4(93/102), CD5(87/102),and also expressed multiple T-follicular helper(TFH) related markers, including BCL6(79/102), CD10(44/102), PD1(75/102), CXCL13(43/102), inducible co-stimulator(ICOS)(99/102).FDC markers, CD21 and CD23, typically highlighted extensive FDC meshworks outside of the follicles. Next generation sequencing(NGS) identified the following 4 characteristic molecular mutations in 40 AITL patients, TET2(31/40),DNMT3A(9/40),IDH2(18/40),RHOA(23/40). Conclusion: The diagnosis of AITL is challenging and requires a constellation of clinical, histomorphological, immunohistochemical and genetic findings. ICOS is a more useful TFH cell marker for the diagnosis of AITL than others.

参考文献：

[1] ALAGGIO R,AMADOR C,ANAGNOSTOPOULO S,et al.The 5th edition of the world health organization classification of haematolymphoid tumours:lymphoid neoplasms[J].Leukemia,2022,36(7):1720-1748.
[2] SWERDLOW S H,HARRIS N L,JAFFE E S,et al.WHO classification of tumours of haematopoietic and lymphoid tissues.WHO classification of tumours[M].Revised 4th edition.Lyon:IARC,2017:407-408.
[3] 杨晓俊,侯宁,史传兵.单形性亲上皮性肠道T细胞淋巴瘤的病理学特征及MATK表达的诊断价值[J].东南大学学报(医学版),2022,41(2):250-255.
[4] XIE Y,JAFFE E S.How I diagnose angioimmunoblastic T-cell lymphoma[J].Am J Clin Pathol,2021,156(1):1-14.
[5] CHIBA S,SAKATA-YANAGIMOTO M.Advances in understanding of angioimmunoblastic T-cell lymphoma[J].Leukemia,2020,34(10):2592-2606.
[6] MOHAMMED SALEH M F,KOTB A,ABDALLAH G E M,et al.Recent advances in diagnosis and therapy of angioimmunoblastic T cell lymphoma[J].Curr Oncol,2021,28(6):5480-5498.
[7] BAYDA N,TILLOY V,CHAUNAVEL A,et al.Comprehensive Epstein-Barr virus transcriptome by RNA-sequencing in angioimmunoblastic T cell lymphoma(AITL) and other lymphomas[J].Cancers(Basel),2021,13(4):610.
[8] BAHRI R,BOYER F,HALABI M A.Epstein-Barr virus(EBV) is mostly latent and clonal in angioimmunoblastic T cell lymphoma(AITL)[J].Cancers(Basel),2022,14(12):2899.
[9] DENG S,LIN S,SHEN J,et al.Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma:a meta-analysis[J].Onco Targets Ther,2019,12:2335-2342.
[10] KRUG A,TARI G,SAIDANE A,et al.Novel T follicular helper-like T-Cell lymphoma therapies:from preclinical evaluation to clinical reality[J].Cancers(Basel),2022,14(10):2392.
[11] BRINK M,MEEUWES F O,VAN DER POEL M W M,et al.Impact of etoposide and ASCT on survival among patients aged<65 years with stage Ⅱ to Ⅳ PTCL:a population-based cohort study[J].Blood,2022,140(9):1009-1019.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录